{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T09:34:51Z","timestamp":1779183291179,"version":"3.51.4"},"reference-count":42,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Glucagon-like peptide-1 (GLP-1)-based medicines have recently been widely used to treat type 2 diabetic patients, whereas adverse effects of nausea and vomiting have been documented. Inhibition of voltage-gated K+ channel subtype Kv2.1 in pancreatic \u03b2-cells has been suggested to contribute to mild depolarization and promotion of insulin release. This study aimed to determine whether the blockade of Kv2.1 channels potentiates the insulinotropic effect of GLP-1 agonists. Kv2.1 channel blocker guangxitoxin-1E (GxTx) and GLP-1 agonist exendin-4 at subthreshold concentrations, when combined, markedly increased the insulin release and cytosolic Ca2+ concentration ([Ca2+]i) in a glucose-dependent manner in mouse islets and \u03b2-cells. Exendin-4 at subthreshold concentration alone increased islet insulin release and \u03b2-cell [Ca2+]i in Kv2.1+\/\u2212 mice. The [Ca2+]i response to subthreshold exendin-4 and GxTx in combination was attenuated by pretreatment with protein kinase A inhibitor H-89, indicating the protein kinase A dependency of the cooperative effect. Furthermore, subthreshold doses of GxTx and GLP-1 agonist liraglutide in combination markedly increased plasma insulin and improved glucose tolerance in diabetic db\/db mice and NSY mice. These results demonstrate that a modest suppression of Kv2.1 channels dramatically raises insulinotropic potency of GLP-1-based drugs, which opens a new avenue to reduce their doses and associated adverse effects while achieving the same glycemic control in type 2 diabetes.<\/jats:p>","DOI":"10.1210\/en.2014-1728","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T17:22:49Z","timestamp":1413998569000},"page":"114-123","source":"Crossref","is-referenced-by-count":11,"title":["Partial Blockade of Kv2.1 Channel Potentiates GLP-1's Insulinotropic Effects in Islets and Reduces Its Dose Required for Improving Glucose Tolerance in Type 2 Diabetic Male Mice"],"prefix":"10.1210","volume":"156","author":[{"given":"Rauza","family":"Sukma Rita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Dezaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyuki","family":"Kurashina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kakei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Yada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071614195247200_B1","doi-asserted-by":"crossref","first-page":"32241","DOI":"10.1074\/jbc.271.50.32241","article-title":"Expression and function of pancreatic \u03b2-cell delayed rectifier K+ channels. Role in stimulus-secretion coupling","volume":"271","author":"Roe","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071614195247200_B2","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/mend.15.8.0685","article-title":"Members of the Kv1 and Kv2 voltage-dependent K+ channel families regulate insulin secretion","volume":"15","author":"MacDonald","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071614195247200_B3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diabetes.53.3.597","article-title":"Expression of voltage-gated potassium channels in human and rhesus pancreatic islets","volume":"53","author":"Yan","year":"2004","journal-title":"Diabetes"},{"key":"2020071614195247200_B4","doi-asserted-by":"crossref","first-page":"44938","DOI":"10.1074\/jbc.M205532200","article-title":"Inhibition of Kv2.1 voltage-dependent K+ channels in pancreatic \u03b2-cells enhances glucose-dependent insulin secretion","volume":"277","author":"MacDonald","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071614195247200_B5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00125-003-1159-8","article-title":"Voltage-dependent K+ channels in pancreatic \u03b2 cells: role, regulation and potential as therapeutic targets","volume":"46","author":"MacDonald","year":"2003","journal-title":"Diabetologia"},{"key":"2020071614195247200_B6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1113\/jphysiol.2005.089375","article-title":"Biophysical and pharmacological properties of the voltage-gated potassium current of human pancreatic \u03b2-cells","volume":"567","author":"Herrington","year":"2005","journal-title":"J Physiol"},{"key":"2020071614195247200_B7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/diabetes.55.04.06.db05-0788","article-title":"Blockers of the delayed-rectifier potassium current in pancreatic \u03b2-cells enhance glucose-dependent insulin secretion","volume":"55","author":"Herrington","year":"2006","journal-title":"Diabetes"},{"key":"2020071614195247200_B8","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1152\/ajpendo.00054.2005","article-title":"Delayed-rectifier (KV2.1) regulation of pancreatic \u03b2-cell calcium responses to glucose: inhibitor specificity and modeling","volume":"289","author":"Tamarina","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071614195247200_B9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cmet.2007.07.010","article-title":"Kv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretion","volume":"6","author":"Jacobson","year":"2007","journal-title":"Cell Metab"},{"key":"2020071614195247200_B10","doi-asserted-by":"crossref","first-page":"23128","DOI":"10.1074\/jbc.M113.491654","article-title":"Control of voltage-gated potassium channel Kv2.2 expression by pyruvate-isocitrate cycling regulates glucose-stimulated insulin secretion","volume":"288","author":"Jensen","year":"2013","journal-title":"J Biol Chem"},{"key":"2020071614195247200_B11","doi-asserted-by":"crossref","first-page":"e56365","DOI":"10.1371\/journal.pone.0056365","article-title":"An exploratory study of the association between KCNB1 rs1051295 and type 2 diabetes and its related traits in Chinese Han population","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"2020071614195247200_B12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2337\/diab.47.2.159","article-title":"Glucagon-like peptides","volume":"47","author":"Drucker","year":"1998","journal-title":"Diabetes"},{"key":"2020071614195247200_B13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/endo.142.2.7983","article-title":"Minireview: the glucagon-like peptides","volume":"142","author":"Drucker","year":"2001","journal-title":"Endocrinology"},{"key":"2020071614195247200_B14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial","volume":"373","author":"Garber","year":"2009","journal-title":"Lancet"},{"key":"2020071614195247200_B15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/dc08-1355","article-title":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"2020071614195247200_B16","doi-asserted-by":"crossref","first-page":"19333","DOI":"10.1073\/pnas.0707054104","article-title":"Essential role of Epac2\/Rap1 signaling in regulation of insulin granule dynamics by cAMP","volume":"104","author":"Shibasaki","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614195247200_B17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1210\/endo.133.4.8404610","article-title":"Glucagon-like peptide-1-(7\u201336)amide and a rise in cyclic adenosine 3\u2032,5\u2032-monophosphate increase cytosolic free Ca2+ in rat pancreatic \u03b2-cells by enhancing Ca2+ channel activity","volume":"133","author":"Yada","year":"1993","journal-title":"Endocrinology"},{"key":"2020071614195247200_B18","doi-asserted-by":"crossref","first-page":"S443","DOI":"10.2337\/diabetes.51.2007.S443","article-title":"Glucagon-like peptide-1 receptor activation antagonizes voltage-dependent repolarizing K+ currents in \u03b2-cells: a possible glucose-dependent insulinotropic mechanism","volume":"51","author":"MacDonald","year":"2002","journal-title":"Diabetes"},{"key":"2020071614195247200_B19","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.2337\/diabetes.53.12.3142","article-title":"Endogenous ghrelin in pancreatic islets restricts insulin release by attenuating Ca2+ signaling in \u03b2-cells: implication in the glycemic control in rodents","volume":"53","author":"Dezaki","year":"2004","journal-title":"Diabetes"},{"key":"2020071614195247200_B20","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.febslet.2009.05.050","article-title":"Regulation of voltage-gated K+ channels by glucose metabolism in pancreatic \u03b2-cells","volume":"583","author":"Yoshida","year":"2009","journal-title":"FEBS Lett"},{"key":"2020071614195247200_B21","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2337\/db07-0345","article-title":"Ghrelin uses G\u03b1i2 and activates voltage-dependent K+ channels to attenuate glucose-induced Ca2+ signaling and insulin release in islet \u03b2-cells: novel signal transduction of ghrelin","volume":"56","author":"Dezaki","year":"2007","journal-title":"Diabetes"},{"key":"2020071614195247200_B22","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.2337\/db06-0878","article-title":"Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance","volume":"55","author":"Dezaki","year":"2006","journal-title":"Diabetes"},{"key":"2020071614195247200_B23","doi-asserted-by":"crossref","first-page":"E745","DOI":"10.1152\/ajpendo.00030.2002","article-title":"The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases \u03b2-cell mass in diabetic mice","volume":"283","author":"Rolin","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071614195247200_B24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.112.199083","article-title":"The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets","volume":"344","author":"Li","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"2020071614195247200_B25","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.2165\/11208110-000000000-00000","article-title":"Liraglutide: a review of its use in the management of type 2 diabetes mellitus","volume":"71","author":"Perry","year":"2011","journal-title":"Drugs"},{"key":"2020071614195247200_B26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"2020071614195247200_B27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2337\/diabetes.52.2.380","article-title":"The influence of GLP-1 on glucose-stimulated insulin secretion: effects on \u03b2-cell sensitivity in type 2 and nondiabetic subjects","volume":"52","author":"Kjems","year":"2003","journal-title":"Diabetes"},{"key":"2020071614195247200_B28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients","volume":"50","author":"Vilsb\u00f8ll","year":"2001","journal-title":"Diabetes"},{"key":"2020071614195247200_B29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.2040-1124.2011.00184.x","article-title":"DPP-4 inhibition and islet function","volume":"3","author":"Ahr\u00e9n","year":"2012","journal-title":"J Diabetes Investig"},{"key":"2020071614195247200_B30","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.2337\/db14-0052","article-title":"Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors","volume":"63","author":"Omar","year":"2014","journal-title":"Diabetes"},{"key":"2020071614195247200_B31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"2020071614195247200_B32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"2020071614195247200_B33","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1016\/j.febslet.2012.06.034","article-title":"Exogenous and endogenous ghrelin counteracts GLP-1 action to stimulate cAMP signaling and insulin secretion in islet \u03b2-cells","volume":"586","author":"Damdindorj","year":"2012","journal-title":"FEBS Lett"},{"key":"2020071614195247200_B34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/ncb874","article-title":"A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK","volume":"4","author":"Enserink","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2020071614195247200_B35","doi-asserted-by":"crossref","first-page":"20829","DOI":"10.1074\/jbc.M001113200","article-title":"Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs","volume":"275","author":"de Rooij","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071614195247200_B36","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/db12-1394","article-title":"Pancreatic \u03b2-cell response to increased metabolic demand and to pharmacologic secretagogues requires EPAC2A","volume":"62","author":"Song","year":"2013","journal-title":"Diabetes"},{"key":"2020071614195247200_B37","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/db11-0368","article-title":"Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet \u03b2-cells","volume":"60","author":"Dezaki","year":"2011","journal-title":"Diabetes"},{"key":"2020071614195247200_B38","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/cdd.2011.102","article-title":"Pancreatic \u03b2-cell prosurvival effects of the incretin hormones involve post-translational modification of Kv2.1 delayed rectifier channels","volume":"19","author":"Kim","year":"2012","journal-title":"Cell Death Differ"},{"key":"2020071614195247200_B39","doi-asserted-by":"crossref","first-page":"52446","DOI":"10.1074\/jbc.M307612200","article-title":"Antagonism of rat \u03b2-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP\/protein kinase A and phosphatidylinositol 3-kinase signaling pathways","volume":"278","author":"MacDonald","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071614195247200_B40","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.2337\/diab.46.11.1755","article-title":"GLP-I(7\u201336) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic \u03b2-cell in a cAMP-dependent manner","volume":"46","author":"Suga","year":"1997","journal-title":"Diabetes"},{"key":"2020071614195247200_B41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2337\/db10-0276","article-title":"Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice","volume":"60","author":"Uchida","year":"2011","journal-title":"Diabetes"},{"key":"2020071614195247200_B42","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.2337\/db13-1868","article-title":"Involvement of cAMP\/EPAC\/TRPM2 activation in glucose- and incretin-induced insulin secretion","volume":"63","author":"Yoshida","year":"2014","journal-title":"Diabetes"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/1\/114\/8854679\/endo0114.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/156\/1\/114\/8854679\/endo0114.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:59:01Z","timestamp":1594951141000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/156\/1\/114\/2800622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2014-1728","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}